Follow
Peter Stärkel
Peter Stärkel
Cliniques Universitaires Saint Luc, Université Catholique de Louvain
Verified email at uclouvain.be
Title
Cited by
Cited by
Year
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
20602017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
14642018
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
S Leclercq, S Matamoros, PD Cani, AM Neyrinck, F Jamar, P Stärkel, ...
Proceedings of the National Academy of Sciences 111 (42), E4485-E4493, 2014
8332014
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
AW Yan, D E. Fouts, J Brandl, P Stärkel, M Torralba, E Schott, ...
Hepatology 53 (1), 96-105, 2011
8212011
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
5562014
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
YI Duan, C Llorente, S Lang, K Brandl, H Chu, LU Jiang, RC White, ...
Nature 575 (7783), 505-511, 2019
5542019
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
4072014
Intestinal fungi contribute to development of alcoholic liver disease
AM Yang, T Inamine, K Hochrath, P Chen, L Wang, C Llorente, S Bluemel, ...
The Journal of clinical investigation 127 (7), 2829-2841, 2017
3902017
Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation
L Wang, DE Fouts, P Stärkel, P Hartmann, P Chen, C Llorente, J DePew, ...
Cell host & microbe 19 (2), 227-239, 2016
3282016
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice
P Chen, M Torralba, J Tan, M Embree, K Zengler, P Stärkel, ...
Gastroenterology 148 (1), 203-214. e16, 2015
3062015
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017
3032017
Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
P Chen, P Stärkel, JR Turner, SB Ho, B Schnabl
Hepatology 61 (3), 883-894, 2015
2972015
Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects
S Leclercq, PD Cani, AM Neyrinck, P Stärkel, F Jamar, M Mikolajczak, ...
Brain, behavior, and immunity 26 (6), 911-918, 2012
2952012
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2712014
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
A Werion, L Belkhir, M Perrot, G Schmit, S Aydin, Z Chen, A Penaloza, ...
Kidney international 98 (5), 1296-1307, 2020
2652020
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
B Delire, P Stärkel
European journal of clinical investigation 45 (6), 609-623, 2015
2512015
Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice
P Hartmann, P Chen, HJ Wang, L Wang, DF McCole, K Brandl, P Stärkel, ...
Hepatology 58 (1), 108-119, 2013
2432013
Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice
T Hendrikx, YI Duan, Y Wang, JH Oh, LM Alexander, W Huang, P Stärkel, ...
Gut 68 (8), 1504-1515, 2019
2242019
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
P Hartmann, K Hochrath, A Horvath, P Chen, CT Seebauer, C Llorente, ...
Hepatology 67 (6), 2150-2166, 2018
2242018
Animal models for the study of hepatic fibrosis
P Starkel, IA Leclercq
Best practice & research Clinical gastroenterology 25 (2), 319-333, 2011
2202011
The system can't perform the operation now. Try again later.
Articles 1–20